The purpose of this study is to determine whether a standardised osteopathic manipulative treatment is more effective than a placebo of osteopathic manipulative treatment, in sub-acute and chronic non-specific low back pain on functional recovery at 3 months.
Sub-acute (4-12-week duration) and chronic (more than 3-month duration) non-specific low back pain (LBP) is frequent, disabling and costly. The effectiveness of usual treatments (including pain killers, anti-inflammatory drugs, spinal injections, physiotherapy, spinal traction, transcutaneous electrical nerve stimulation, etc) may be not sufficient, and many patients resort to alternative therapies. Manipulative treatments represent en emerging therapy in this area, although studies assessing their effectiveness are limited and often biased. The purpose of this study is to evaluate the efficacy of two manual therapies on improving functional recovery in sub-acute and chronic non-specific low back pain at 3 months. A standardised osteopathic manipulative treatment is compare to a placebo of osteopathic manipulative treatment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
400
A standardized manipulative treatment according to the results of a physical examination including 7 anatomical areas will be given by trained osteopaths during 6 sessions (with an interval of 2 weeks between 2 sessions). Each session will last 45 minutes. Osteopaths will have 3 days of training in standardized manipulative treatment.
A standardized placebo of manipulative treatment consisting in "light touch" and according to the results of a physical examination including 7 anatomical areas will be given by trained osteopaths during 6 sessions (with an interval of 2 weeks between 2 sessions). Each session will last 45 minutes. Osteopaths will have 3 days of training in standardized placebo of manipulative treatment.
CHU Cochin
Paris, France
Mean improvement from baseline in mean activity limitation
Assessed with the self-administered Quebec functional scale (from 0, no limitation to 100, maximal limitation)
Time frame: 3 months after randomization
Mean reduction from baseline in mean lumbar pain in the previous 48 hrs
assessed with a self-administered 11-class numeric scale (from 0 no pain to 100, maximal pain)
Time frame: 3 months after randomization
Mean reduction from baseline in mean lumbar pain in the previous 48 hrs
assessed with a self-administered 11-class numeric scale (from 0, no pain to 100, maximal pain)
Time frame: 12 months after randomization
Number of sick leaves
self-reported number of sick leaves
Time frame: 12 months after randomization
Duration of sick leaves
self-reported total duration (days) of sick leaves
Time frame: 12 months after randomization
Recurrence of pain
self-reported number of low back pain episodes
Time frame: 12 months after randomization
Mean improvement from baseline in mean activity limitation
Assessed with the self-administered Quebec functional scale (from 0, no limitation to 100, maximal limitation)
Time frame: 12 months after randomization
Mean improvement from baseline in mean quality of life
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Assessed with the physical and mental components of the self-administered MOS SF-12 questionnaire (from 0, worse quality of life to 100, best quality of life)
Time frame: 3 months after randomization
Mean improvement from baseline in mean quality of life
Assessed with the physical and mental components of the self-administered MOS SF-12 questionnaire (from 0, worse quality of life to 100, best quality of life)
Time frame: 12 months after randomization
Pain killer and non-steroidal anti-inflammatory drug consumption
self-reported consumption of pain killer and non-steroidal anti-inflammatory drugs since last contact ( yes/no)
Time frame: 3 months after randomization
Pain killer and non-steroidal anti-inflammatory drug consumption
self-reported consumption of pain killer and non-steroidal anti-inflammatory drugs since last contact ( yes/no)
Time frame: 12 months after randomization